UNBS-1450

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUNBS-1450
Drug Alias NameUNBS-1450UBS-1450
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockersNuclear factor NF-kappa-B complex inhibitors
TargetsSodium channel alpha subunitNuclear factor NF-kappa-B complex
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUnibioscreen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnibioscreen
Active IndicationsN/A
Inactive IndicationsLymphoma

Other Information

ATC CodeN/A
Related LinksN/A